1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
(
- Contribution to journal › Article
- 2019
-
Mark
Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes
(
- Contribution to journal › Article
- 2018
-
Mark
Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes
(
- Contribution to journal › Article
- 2017
-
Mark
European Respiratory Society statement : Diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency : an open-label extension trial (RAPID-OLE)
(
- Contribution to journal › Article
-
Mark
SAMPA Chip : The New 32 Channels ASIC for the ALICE TPC and MCH Upgrades
(
- Contribution to journal › Article
- 2015
-
Mark
Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
(
- Contribution to journal › Article
- 2014
-
Mark
Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease.
(
- Contribution to journal › Article